Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Genomic Health next reports earnings on April 28, 2014.
To re ceive a free e-mail notification whenever Genomic Health makes a similar move, sign up!
Other recent filings from the company include the following:
Genomic Health's President and CEO just cashed-in 4,300 options - Nov. 14, 2014
Genomic Health's COO just cashed-in 4,000 options - Nov. 12, 2014
Genomic: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers - Nov. 10, 2014
Genomic Health director just cashed-in 3,000 options - Nov. 5, 2014
Genomic Health Announces Third Quarter 2014 Financial Results And Reports Continued Growth In U.S. Invasive Breast Cancer Business - Nov. 4, 2014